News
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...
Capricor Therapeutics said on Friday the U.S. Food and Drug Administration has declined to approve its cell therapy ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
“We want to focus on food. People forget that the ‘F’ in FDA stands for food,” Makary said. Makary noted that the processed ...
Explore more
A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment ...
Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” ...
The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results